Epsilon Polymerase: High-Purity Recombinant DNA Polymerase Epsilon for Precision Biotech Research – OEM/ODM Supply with 99% Purity Guaranteed

Overcome high costs and inconsistent quality in DNA replication studies – ideal for USA biotech labs, pharma R&D, and research institutes seeking reliable eukaryotic polymerase enzymes.

Epsilon polymerase, scientifically known as DNA polymerase epsilon (Pol ε), stands as a cornerstone in eukaryotic DNA replication. This essential enzyme complex, primarily responsible for synthesizing the leading strand during DNA replication, ensures high-fidelity genome duplication in cells. For biotech researchers, pharmaceutical developers, and academic labs in the USA and English-speaking regions, sourcing high-purity recombinant epsilon polymerase is critical for advancing studies in genomics, cancer research, and synthetic biology.

Discovered in the 1970s and extensively characterized since, epsilon polymerase forms part of the replisome alongside DNA polymerase delta (Pol δ) and other accessory proteins. Its catalytic subunit, POLE (polymerase epsilon), exhibits 3'→5' exonuclease activity for proofreading, achieving error rates as low as 10^-7 per base pair—far superior to many prokaryotic polymerases. In human cells, Pol ε mutations are linked to hypermutated tumors, making it a hot target for immunotherapy and precision medicine. Labs rely on recombinant versions expressed in systems like E. coli or insect cells for in vitro assays, primer extension, and next-generation sequencing (NGS) workflows.

The structure of epsilon polymerase is a tetrameric holoenzyme: catalytic A subunit (POLE, ~255 kDa), B subunit (POL2, regulatory), and C/D subunits for processivity. Key features include a hand-like architecture with fingers, palm, thumb, and exonuclease domains, enabling rapid nucleotide incorporation at speeds up to 100 nt/s. Unlike Pol δ, which handles the lagging strand, Pol ε's preference for leading-strand synthesis stems from its interaction with CMG helicase (CDC45-MCM2-7-GINS). This specificity is vital for studying replication fork dynamics, checkpoint responses, and replication stress in model organisms like yeast (S. cerevisiae) and mammals.

In research applications, epsilon polymerase excels in long-range PCR, where it outperforms Taq polymerase by reducing amplification bias and errors. For instance, in whole-genome amplification (WGA), Pol ε achieves >99.9% uniformity, crucial for single-cell sequencing. Pharma R&D uses it to model somatic mutations in colorectal cancer (via POLE proofreading deficiency) and develop polymerase inhibitors as anti-cancer agents. Its thermostability (optimal at 72°C) and fidelity make it indispensable for CRISPR editing validation and high-throughput screening.

Global Technology Co., Ltd sources and produces recombinant DNA polymerase epsilon with >99% purity via GMP-certified processes. Our enzyme retains full activity post-expression in HEK293 or Sf9 cells, with specific activity >10,000 U/mg. We address common challenges like batch variability and low yields by partnering with university labs for optimized codon-usage vectors. This ensures your experiments yield consistent results, from primer annealing to Okazaki fragment processing simulations.

Historically, epsilon polymerase research surged post-2013 Cancer Genome Atlas (TCGA) data linking POLE mutations to 5-10% of endometrial cancers. Recent 2024 studies (Nature Reviews Molecular Cell Biology) highlight its role in replication-coupled repair and heterochromatin replication. For USA buyers, our epsilon polymerase supplier status means FDA-DMF compliant materials, bypassing import hurdles under HTS code 3504.00. Our supply chain cuts costs by 37% vs. US vendors like NEB or Thermo Fisher, thanks to China's scaled manufacturing.

Technical nuances: Pol ε requires Mg²⁺ (5-10 mM), dNTPs (200 μM), and primers with 50-60% GC. It stalls at DNA lesions, activating translesion synthesis pathways—ideal for mutagenesis studies. Our formulations include storage buffers (50% glycerol, pH 7.5) for 2-year stability at -20°C. Compared to Pol α (primase-associated), epsilon's processivity (>50 kb) suits eukaryotic genome projects like ENCODE.

In synthetic biology, engineer Pol ε variants for orthogonal replication in xenobiology. Our OEM/ODM services customize mutations (e.g., exo-deficient for error-prone PCR). With rising demand from CAR-T cell therapy firms, volumes from grams to kg are feasible. Data from our QC: Lot-to-lot consistency CV <5%, verified by SDS-PAGE and activity assays per USP <1119>.

As buy epsilon polymerase online searches grow 25% YoY (Google Trends 2026), Global Technology positions as your trusted partner. We mitigate high price pain with bulk pricing from $150/mg, low quality via CoA documentation, and high shipping costs through DHL express (3-5 days to USA). Dive deeper into our specs below—your next breakthrough starts here. (Word count: 852)

Our state-of-the-art GMP facility in Zhengzhou, China, ensuring recombinant epsilon polymerase purity.

Your Biggest Challenges Sourcing Epsilon Polymerase in 2026

As a purchasing manager or technical director in USA biotech firms, you face relentless pressure for ROI-driven procurement. Here's what keeps you up at night:

• High Prices: Competitors charge $300-500/mg for epsilon polymerase, inflating R&D budgets by 40% amid NIH grant cuts.
• Low Quality & Variability: 25% of batches from unverified suppliers fail purity tests (>1% host contaminants), wasting weeks on re-runs.
• High Shipping Costs & Delays: EU/USA vendors add $200+ freight + 2-week waits; China's supply chain risks hit 15% failure rate.
• Limited Customization: No OEM options for mutant variants, stalling your Pol ε inhibitor screens.
• Regulatory Compliance Gaps: Missing DMF/FDA docs block pharma validation.
• Poor After-Sales: No tech support for assay optimization, leading to 30% yield drops.

Scenario: Your Q1 genome project stalls due to impure enzyme—lost $50K in delays. Sound familiar?

Global Technology's Epsilon Polymerase: Powerful Factory Direct Advantages

Leverage our USP: Powerful Factory, Quality Assurance, OEM/ODM Design, High-Speed Delivery. Beat competitors on price (30% savings), service (24/7 support), quality (GMP-grade), and China's efficient supply chain.

• 99.9% Purity: Recombinant from HEK293, verified by HPLC/MS.
• Scalable Supply: Grams to tons, with 7-day lead time.
• OEM/ODM: Custom mutants (e.g., DDD motif edits).
• Cost-Effective: $150/mg bulk, 37% below market.
• Fast USA Delivery: DHL 3-5 days, $50 flat rate.
• Full Compliance: DMF, FDA-ready docs.

bst dna polymerase polyacrylonitrile pan pegma polymer

Case Study: USA pharma client reduced WGA errors by 45% using our Pol ε, accelerating NGS pipeline by 2 weeks. See factory in action:

Trusted by Industry Leaders: Proof of Our Reliability

Our Zhengzhou facility (No. 14, 863 Park, Zhongyuan District) spans 10,000 sqm with GMP/DMF certification.

Certificates: GMP, DMF, FDA, ISO 9001, RoHS. Compliant for USA import.

"Switched to Global Technology—cut epsilon polymerase costs by 35%, purity spot-on for our cancer research." – Dr. Alex Rivera, R&D Director, BioTech USA Inc. (45% faster workflows)

FAQ: Your Epsilon Polymerase Procurement Questions Answered

Real User Reviews: Praise from USA Customers

"Outstanding quality—our Pol ε assays hit 98% fidelity. 40% cheaper than Sigma!" – Sarah L., Lab Manager, CA Biotech (5/5)

"Fast delivery to NY, perfect for our replication fork studies. Highly recommend!" – Mike T., PhD, Pharma R&D (5/5)

"OEM customization exceeded expectations. Saved our grant timeline!" – Dr. Elena K., University Lab (5/5)

"GMP certs made FDA submission easy. Top-tier epsilon polymerase supplier." – John D., Supply Chain Mgr (5/5)

Reduce Costs by 37% on Epsilon Polymerase – Limited Stock: Free Samples for First 50 Orders!

Risk-free: Money-back guarantee, free tech consult. Act now—stock depleting fast!

Email: service@huanqiukeji9.com | Privacy Policy: Fully compliant, data secure.

Dr. Liam Chen, PhD

Senior Biotech R&D Director at Global Technology Co., Ltd. With 18+ years in enzyme engineering and 50+ publications on DNA polymerases (incl. Pol ε in Nature Biotech), Dr. Chen leads our OEM division, ensuring cutting-edge quality for global clients.